TATIANA HARDY: Open Payments
NPI 1538511753 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,171 in 37 payments from 11 companies in 2025. Trend: 2023 $176 · 2024 $357 · 2025 $1,171
Food & beverage: $1,171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $281 |
| Novo Nordisk Inc | 13 | $261 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $193 |
| Amgen Inc. | 2 | $164 |
| Lilly USA, LLC | 7 | $129 |
| Janssen Pharmaceuticals, Inc | 2 | $44 |
| Bausch Health US, LLC | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
Products named: AIRSUPRA, Kerendia, REPATHA, MOUNJARO, Wegovy, SPRAVATO, JARDIANCE, Rybelsus.
Industry payments across NC — which companies pay providers there.
